Japan Contract Development Manufacturing Organization Market Report 2024-2030, Featuring Lonza, Recipharm, LabCorp, Catalent, WuXi AppTec, CordenPharma, Cambrex, Bushu Pharmaceuticals and ...
Labcorp Holdings Inc. (LH)
Last labcorp holdings inc. earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
Manufacturing Organization Market Size, Share & Trends Analysis Report by Product Type (API, Drug Product), Workflow (Clinical, Commercial), Application (Oncology, Hormonal, Glaucoma), Country, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The Japan CDMO market is expected to reach USD 19.49 billion by 2030 and is projected to register a CAGR of 6.8% from 2024 to 2030. The increasing demand for biopharmaceuticals, a high burden of diseases, and the rising geriatric population are some of the key growth drivers. Growing investments by various Contract Development and Manufacturing Organizations (CDMOs) for facility and service expansion are likely to boost the market over the forecast period. In addition, increasing pharmaceutical R&D investments are driving the market growth. As pharmaceutical companies invest more in R&D, they may seek external expertise and resources to accelerate drug development processes. CDMOs provide special
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Labcorp Holdings Inc. news events
Weekly update
A roundup of the hottest topics
LH
News
- Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive OfficerBusiness Wire
- Labcorp to Announce Third Quarter Financial Results on October 24, 2024PR Newswire
- Laboratory Co. of America Holdings (NYSE: LH) had its price target lowered by analysts at Evercore ISI from $250.00 to $240.00. They now have an "in-line" rating on the stock.MarketBeat
- LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion [Yahoo! Finance]Yahoo! Finance
LH
Earnings
- 8/1/24 - Beat
LH
Sec Filings
- 9/24/24 - Form 8-K
- 9/23/24 - Form 8-K
- 9/18/24 - Form 8-K
- LH's page on the SEC website